Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

NCT05272059 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: MHS552
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals